National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 02:56:51

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0169-1833-11	ML - Milliliter	0169-1833	e4dc9769-c046-4f7b-83fd-a7c902a72d0d	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0169-1833	0169-1833-11

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
019938	Novolin R	insulin human	351(a)	OTC	2026-09-01

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Novolin R	HUMAN INSULIN	Novo Nordisk	aee7f1f3-612c-4027-8ce9-4fd1f41eed71	2022-11-23	Warnings, Adverse reactions	Exact identifier ndc (package): 0169-1833-11 ndc11 (package): 00169183311

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.